By Professor Andrew Lloyd

Books

, 2009, Hepatitis C: An Expanding Perspective, Dore GJ; Dore G; Lloyd AROLA, (eds.), IP Communications, East Hawthorn

Book Chapters

Lloyd AR; Hickie I; Wakefield D, 2022, 'Chronic fatigue and postinfective fatigue syndromes', in Clinical Virology: Third Edition, pp. 371 - 383, http://dx.doi.org/10.1128/9781555815981.ch17

Cameron B; Bierl C; Davenport T; Vollmer-Conna U; Hickie I; Wakefield D; Lloyd AR, 2021, 'Drought and Q fever: The association between trends in the incidence of infection and rainfall in rural Australia', in The Encyclopedia of Bacteriology Research Developments, pp. 1975 - 1988

Chang CC; Crane M; Jaworowski A; Lloyd A; French MA; Lewin SR, 2018, 'Immunopathogenesis of HIV Coinfections', in Encyclopedia of AIDS, Springer New York, pp. 1083 - 1096, http://dx.doi.org/10.1007/978-1-4939-7101-5_179

Cameron B; Bierl C; Davenport T; Vollmer-Conna U; Hickie I; Wakefield D; Lloyd AR, 2017, 'Drought and q fever: The association between trends in the incidence of infection and rainfall in rural australia', in The Principles and Practice of Q Fever: The One Health Paradigm, pp. 301 - 315

Lloyd A, 2017, 'Chronic Fatigue and Postinfective Fatigue Syndromes', in Clinical Virology, Fourth Edition, American Society for Microbiology, pp. 373 - 384, http://dx.doi.org/10.1128/9781555819439.ch18

Lloyd AR, 2016, 'Chronic fatigue and postinfective fatigue syndromes', in Clinical Virology, pp. 371 - 384, http://dx.doi.org/10.1128/9781555819439.ch18

Chang CC; Crane M; Jaworowski A; Lloyd A; French MA; Lewin SR, 2014, 'Immunopathogenesis of HIV Coinfections', in Encyclopedia of AIDS, Springer New York, pp. 1 - 15, http://dx.doi.org/10.1007/978-1-4614-9610-6_179-1

Oldmeadow M; Lloyd AROLA, 2009, 'Fatigue states following infection', in Yung A; McDonald M; Spelman D; Street A; Johnson P; Sorrell T; McCormack J (ed.), Infectious Diseases A clinical approach, IP Communications, East Hawthorn, Victoria, Australia

Dore GJ; Temple-Smith M; Lloyd AROLA, 2009, 'Future challenges for hepatitis C', in Dore G; Temple-Smith M; Lloyd A (ed.), Hepatitis C: An Expanding Perspective, IP Communications, East Hawthorn, pp. 433 - 452, http://www.ipcommunications.com.au/

Oldmeadow M; Lloyd AR, 2005, 'Fatigue states following infection', in Yung A; McDonald M; Spelman D; Street A; Johnson P; Sorrell T; McCormack J (ed.), Infectious Diseases A clinical approach, IP Communications, East Hawthorn, Victoria, Australia, pp. 195 - 204

Lloyd AR; Hickie IB; Petersen PK, 1999, 'Chronic fatigue syndrome: current concepts of pathogenesis and treatment', in Current Clinical Topics in Infectious Diseases, Blackwell Science Asia, Carlton, Victoria, pp. 138 - 159

Lloyd AR; Hickie IB; Peterson PK, 1999, 'Chronic fatigue syndrome: current concepts of pathogenesis and treatment.', in Current Clinical Topics in Infectious Diseases, Blackwell Science Asia, Carlton, Victoria, pp. 135 - 159

Lloyd AR; Hickie IB; Peterson PK, 1997, 'Chronic fatigue syndrome', in Clinical Virology, Churchill Livingstone, New York, pp. 343 - 355

Lloyd AR; Hickie IB; Peterson PK, 1997, 'Chronic fatigue syndrome', in Clinical Virology, Churchill Livingstone, New York, pp. 343 - 355

Lloyd AR; Wakefield D, 1997, 'Treatment of chronic fatigue syndrome', in Intravenous Immunoglobulins in Clinical Practice, Marcel Dekker, New York, pp. 267 - 274

DWYER JM; LLOYD AR; HICKIE IB; WAKEFIELD D; BOUGHTON CR, 1991, 'The response of patients with chronic fatigue syndrome to intravenously administered gammaglobulin', in Immunotherapy with Intravenous Immunoglobulins, Elsevier, pp. 377 - 386, http://dx.doi.org/10.1016/b978-0-12-370725-3.50039-7

Journal articles

Gervais A; Bastard P; Bizien L; Delifer C; Tiberghien P; Rodrigo C; Trespidi F; Angelini M; Rossini G; Lazzarotto T; Conti F; Cassaniti I; Baldanti F; Rovida F; Ferrari A; Mileto D; Mancon A; Abel L; Puel A; Cobat A; Rice CM; Cadar D; Schmidt-Chanasit J; Scheid JF; Lemieux JE; Rosenberg ES; Agudelo M; Tangye SG; Borghesi A; Durand GA; Duburcq-Gury E; Valencia BM; Lloyd AR; Nagy A; MacDonald MM; Simonin Y; Zhang SY; Casanova JL, 2024, 'Auto-Abs neutralizing type I IFNs in patients with severe Powassan, Usutu, or Ross River virus disease', The Journal of experimental medicine, 221, http://dx.doi.org/10.1084/jem.20240942

Shrestha LB; Tungatt K; Aggarwal A; Stubis A; Fewings NL; Fichter C; Akerman A; Rodrigo C; Tedla N; Lee S; Lloyd AR; Brilot F; Britton WJ; Kelleher A; Caterson ID; Douglas MW; Rockett R; Tangye SG; Triccas JA; Turville SG; Sandgren KJ; Bull RA; Cunningham AL; Sorrell T; Britton W; Maclean M; Camilleri J; Douglas M; Bull R; Sandgren K; Song Y; Mao L; Phu A; Sigmund A; Beard S; Caterson I; Hunt S; Vande More AM; Kandasamy R; Kok J; Byrne J; Lloyd A; Triccas J; Tangye S; Turville S; O'Sullivan M; Steain M; Baird S; Phetsouphanh C; Zhao Y, 2024, 'Bivalent Omicron BA.1 vaccine booster increases memory B cell breadth and neutralising antibodies against emerging SARS-CoV-2 variants', eBioMedicine, 110, http://dx.doi.org/10.1016/j.ebiom.2024.105461

Walker SJ; Dawson O; Sheehan Y; Shrestha LB; Lloyd AR; Sheehan J; Maduka N; Cabezas J; Kronfli N; Akiyama MJ, 2024, 'Co-designing the INHSU Prisons Hepatitis C Advocacy Toolkit using the Advocacy Strategy Framework', International Journal of Drug Policy, 134, http://dx.doi.org/10.1016/j.drugpo.2024.104628

Bah R; Sheehan Y; Li X; Dore GJ; Grebely J; Lloyd AR; Hajarizadeh B; Bah R; Li C; Byrne M; Butler T; Musarurwa B; Hooshmand E; Simpson A; Alrayyani M; Price N; Groom M, 2024, 'Prevalence of blood-borne virus infections and uptake of hepatitis C testing and treatment in Australian prisons: the AusHep study', The Lancet Regional Health - Western Pacific, 53, http://dx.doi.org/10.1016/j.lanwpc.2024.101240

Ryan H; Dore GJ; Grebely J; Byrne M; Cunningham EB; Martinello M; Lloyd AR; Hajarizadeh B, 2024, 'Hepatitis C treatment outcome among people in prison: The SToP-C study', Liver International, 44, pp. 2996 - 3007, http://dx.doi.org/10.1111/liv.16074

Nibau C; Evans A; King H; Phillips DW; Lloyd A, 2024, 'Homoeologous crossovers are distally biased and underlie genomic instability in first-generation neo-allopolyploid Arabidopsis suecica', New Phytologist, 244, pp. 1315 - 1327, http://dx.doi.org/10.1111/nph.20095

Horsburgh BA; Walker GJ; Kelleher A; Lloyd AR; Bull RA; Giallonardo FD, 2024, 'Next-Generation Sequencing Methods for Near-Real-Time Molecular Epidemiology of HIV and HCV', Reviews in Medical Virology, 34, http://dx.doi.org/10.1002/rmv.70001

Underwood AP; Gupta M; Wu BR; Eltahla AA; Boo I; Wang JJ; Agapiou D; Abayasingam A; Reynaldi A; Keoshkerian E; Zhao Y; Brasher N; Walker MR; Bukh J; Maher L; Gordon T; Davenport MP; Luciani F; Drummer HE; Lloyd AR; Bull RA, 2024, 'B-cell characteristics define HCV reinfection outcome', Journal of Hepatology, 81, pp. 415 - 428, http://dx.doi.org/10.1016/j.jhep.2024.04.004

Lafferty L; Altice FL; Leone F; Stoové M; Lloyd AR; Hajarizadeh B; Kronfli N, 2024, 'Using nominal group technique with people who are incarcerated in Canadian federal prisons to identify barriers and solutions to improving Prison Needle Exchange Program uptake', International Journal of Drug Policy, 131, http://dx.doi.org/10.1016/j.drugpo.2024.104549

Rodrigo C; Walker G; Sevendal ATK; Nguyen C; Stelzer-Braid S; Rawlinson W; Graves S; Gidding HF; Stenos J; Lloyd AR, 2024, 'Acute Q fever in patients with an influenza-like illness in regional New South Wales, Australia', PLoS Neglected Tropical Diseases, 18, http://dx.doi.org/10.1371/journal.pntd.0012385

Cai C; Keoshkerian E; Wing K; Samir J; Effenberger M; Schober K; Bull RA; Lloyd AR; Busch DH; Luciani F, 2024, 'Discovery of a monoclonal, high-affinity CD8⁺ T-cell clone following natural hepatitis C virus infection', Immunology and Cell Biology, 102, pp. 630 - 641, http://dx.doi.org/10.1111/imcb.12791

Sheehan Y; Cochrane A; Treloar C; Grebely J; Tedla N; Lloyd AR; Lafferty L, 2024, 'Understanding hepatitis C virus (HCV) health literacy and educational needs among people in prison to enhance HCV care in prisons', International Journal of Drug Policy, 130, http://dx.doi.org/10.1016/j.drugpo.2024.104516

Kronfli N; Lafferty L; Leone F; Stoové M; Hajarizadeh B; Lloyd AR; Altice FL, 2024, 'Using nominal group technique to identify perceived barriers and facilitators to improving uptake of the Prison Needle Exchange Program in Canadian federal prisons by correctional officers and healthcare workers', International Journal of Drug Policy, 130, http://dx.doi.org/10.1016/j.drugpo.2024.104540

Griffin S; Lee Wilkinson A; Winter R; Hajarizadeh B; MacIsaac M; Papaluca T; Holmes J; Lloyd AR; Carson J; Craigie A; Hellard M; Stoové M; Thompson A, 2024, 'Contribution of prison-based hepatitis C treatment initiations to overall treatment uptake in Victoria, Australia', The Lancet Regional Health - Western Pacific, 48, http://dx.doi.org/10.1016/j.lanwpc.2024.101139

Sheehan Y; Lafferty L; Tedla N; Byrne M; Dawson O; Stewart S; Leber B; Habraken N; Lloyd AR, 2024, 'Development of an evidence-based hepatitis C education program to enhance public health literacy in the Australian prison sector: The Hepatitis in Prisons Education program (HepPEd)', International Journal of Drug Policy, 129, http://dx.doi.org/10.1016/j.drugpo.2024.104461

Bretaña NA; Kwon JA; Grant L; Galouzis J; McGrath C; Hoey W; Blogg J; Lloyd AR; Gray RT, 2024, 'Controlling COVID-19 outbreaks in the correctional setting: A mathematical modelling study', PLoS ONE, 19, http://dx.doi.org/10.1371/journal.pone.0303062

Walker SJ; Shrestha LB; Lloyd AR; Dawson O; Sheehan Y; Sheehan J; Maduka NBC; Cabezas J; Akiyama MJ; Kronfli N, 2024, 'Barriers and advocacy needs for hepatitis C services in prisons: Informing the prisons hepatitis C advocacy toolkit', International Journal of Drug Policy, 126, http://dx.doi.org/10.1016/j.drugpo.2024.104386

Winter RJ; Griffin S; Sheehan Y; Nguyen W; Stoové M; Lloyd AR; Thompson AJ, 2024, 'People in community corrections are a population with unmet need for viral hepatitis care', eClinicalMedicine, 70, http://dx.doi.org/10.1016/j.eclinm.2024.102548

Sheehan Y; Grebely J; Lloyd AR, 2024, 'Reply to: “ ‘One-stop-shop’ point-of-care hepatitis C RNA testing intervention in the prison – some issues”', Journal of Hepatology, 80, pp. e107 - e108, http://dx.doi.org/10.1016/j.jhep.2023.10.020

Shih STF; Stone J; Martin NK; Hajarizadeh B; Cunningham EB; Kwon JA; McGrath C; Grant L; Grebely J; Dore GJ; Lloyd AR; Vickerman P; Chambers GM, 2024, 'Scale-up of Direct-Acting Antiviral Treatment in Prisons Is Both Cost-effective and Key to Hepatitis C Virus Elimination', Open Forum Infectious Diseases, 11, http://dx.doi.org/10.1093/ofid/ofad637

Weickert TW; Jacomb I; Lenroot R; Lappin J; Weinberg D; Brooks WS; Brown D; Pellen D; Kindler J; Mohan A; Wakefield D; Lloyd AR; Stanton C; O'Donnell M; Liu D; Galletly C; Shannon Weickert C, 2024, 'Adjunctive canakinumab reduces peripheral inflammation markers and improves positive symptoms in people with schizophrenia and inflammation: A randomized control trial', Brain, Behavior, and Immunity, 115, pp. 191 - 200, http://dx.doi.org/10.1016/j.bbi.2023.10.012

Bah R; Sheehan Y; Li X; Price N; Butler T; Dore GJ; Grebely J; Lloyd AR; Hajarizadeh B, 2024, 'Challenges and facilitators in repeated bio-behavioural surveys for blood-borne virus infections in Australian prisons', International Journal of Drug Policy, http://dx.doi.org/10.1016/j.drugpo.2024.104401

Adhikari A; Abayasingam A; Brasher NA; Kim HN; Lord M; Agapiou D; Maher L; Rodrigo C; Lloyd AR; Bull RA; Tedla N, 2024, 'Characterization of antibody-dependent cellular phagocytosis in patients infected with hepatitis C virus with different clinical outcomes', Journal of Medical Virology, 96, http://dx.doi.org/10.1002/jmv.29381

Hajarizadeh B; Carson JM; Byrne M; Grebely J; Cunningham E; Amin J; Vickerman P; Martin NK; Treloar C; Martinello M; Lloyd AR; Dore GJ, 2024, 'Incidence of hepatitis C virus infection in the prison setting: The SToP-C study', Journal of Viral Hepatitis, 31, pp. 21 - 34, http://dx.doi.org/10.1111/jvh.13895

Kwon JA; Bretaña NA; Kronfli N; Dussault C; Grant L; Galouzis J; Hoey W; Blogg J; Lloyd AR; Gray RT, 2024, 'Preparing correctional settings for the next pandemic: a modeling study of COVID-19 outbreaks in two high-income countries', Frontiers in Public Health, 12, http://dx.doi.org/10.3389/fpubh.2024.1279572

Dyer WB; Suzuki K; Levert A; Starr M; Lloyd AR; Zaunders JJ, 2024, 'Preservation of functionality, immunophenotype, and recovery of HIV RNA from PBMCs cryopreserved for more than 20 years', Frontiers in Immunology, 15, http://dx.doi.org/10.3389/fimmu.2024.1382711

Wood JG; Heywood AE; Dennington PM; Lloyd AR; Ziegler JB, 2024, 'Trends in intravenous immunoglobulin use in New South Wales, Australia', Internal Medicine Journal, 54, pp. 149 - 156, http://dx.doi.org/10.1111/imj.16175

Cysique LA; Lloyd A, 2024, 'Viruses and pathological brain ageing: a challenge we must confront', Journal and Proceedings of the Royal Society of New South Wales, 157, pp. 92 - 106

White P; Abbey S; Angus B; Ball HA; Buchwald DS; Burness C; Carson AJ; Chalder T; Clauw DJ; Coebergh J; David AS; Dworetzky BA; Edwards MJ; Espay AJ; Etherington J; Fink P; Flottorp S; Garcin B; Garner P; Glasziou P; Hamilton W; Henningsen P; Hoeritzauer I; Husain M; Huys ACML; Knoop H; Kroenke K; Lehn A; Levenson JL; Little P; Lloyd A; Madan I; Van Der Meer JWM; Miller A; Murphy M; Nazareth I; Perez DL; Phillips W; Reuber M; Rief W; Santhouse A; Serranova T; Sharpe M; Stanton B; Stewart DE; Stone J; Tinazzi M; Wade DT; Wessely SC; Wyller V; Zeman A, 2023, 'Anomalies in the review process and interpretation of the evidence in the NICE guideline for chronic fatigue syndrome and myalgic encephalomyelitis', Journal of Neurology, Neurosurgery and Psychiatry, 94, pp. 1056 - 1063, http://dx.doi.org/10.1136/jnnp-2022-330463

Moallemi S; Lloyd AR; Rodrigo C, 2023, 'Early biomarkers for prediction of severe manifestations of dengue fever: a systematic review and a meta-analysis', Scientific Reports, 13, pp. 17485, http://dx.doi.org/10.1038/s41598-023-44559-9

Ng WH; Liu X; Ling ZL; Santos CNO; Magalhães LS; Kueh AJ; Herold MJ; Taylor A; Freitas JR; Koit S; Wang S; Lloyd AR; Teixeira MM; Merits A; Almeida RP; King NJC; Mahalingam S, 2023, 'FHL1 promotes chikungunya and o’nyong-nyong virus infection and pathogenesis with implications for alphavirus vaccine design', Nature Communications, 14, http://dx.doi.org/10.1038/s41467-023-42330-2

Jones MD; Casson SM; Barry BK; Li SH; Valenzuela T; Cassar J; Lamanna C; Lloyd AR; Sandler CX, 2023, 'eLearning improves allied health professionals' knowledge and confidence to manage medically unexplained chronic fatigue states: A randomized controlled trial', Journal of Psychosomatic Research, 173, pp. 111462, http://dx.doi.org/10.1016/j.jpsychores.2023.111462

Sheehan Y; Cunningham EB; Cochrane A; Byrne M; Brown T; McGrath C; Lafferty L; Tedla N; Dore GJ; Lloyd AR; Grebely J, 2023, 'A ‘one-stop-shop’ point-of-care hepatitis C RNA testing intervention to enhance treatment uptake in a reception prison: The PIVOT study', Journal of Hepatology, 79, pp. 635 - 644, http://dx.doi.org/10.1016/j.jhep.2023.04.019

Back to profile page